UnitedHealth Group Incorporated $UNH Shares Purchased by Park Avenue Securities LLC

Park Avenue Securities LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 6.8% in the third quarter, HoldingsChannel reports. The firm owned 39,618 shares of the healthcare conglomerate’s stock after purchasing an additional 2,531 shares during the quarter. Park Avenue Securities LLC’s holdings in UnitedHealth Group were worth $14,543,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. General Partner Inc. bought a new position in shares of UnitedHealth Group in the third quarter worth approximately $512,000. PBCay One RSC Ltd purchased a new stake in shares of UnitedHealth Group during the first quarter valued at approximately $14,343,000. Lee Johnson Capital Management LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $6,180,000. Kinsale Capital Group Inc. raised its holdings in UnitedHealth Group by 13.4% in the 2nd quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate’s stock worth $16,006,000 after acquiring an additional 4,557 shares during the last quarter. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. raised its holdings in UnitedHealth Group by 1,287.2% in the 1st quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate’s stock worth $16,241,000 after acquiring an additional 55,695 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on UNH. Royal Bank Of Canada increased their target price on UnitedHealth Group from $478.00 to $498.00 and gave the company an “outperform” rating in a research note on Tuesday, October 20th. New Street Research set a $402.00 price target on UnitedHealth Group in a report on Friday, October 9th. Robert W. Baird dropped their price objective on UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 14th. Piper Sandler lifted their price objective on UnitedHealth Group from $502.00 to $504.00 and gave the stock an “overweight” rating in a report on Wednesday, October 14th. Finally, Barclays decreased their price objective on shares of UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating for the company in a report on Wednesday, October 14th. Twenty analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $463.93.

Read Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Trading Up 0.0%

UnitedHealth Group stock opened at $410.72 on Wednesday. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The stock has a fifty day moving average of $389.07 and a 200 day moving average of $361.44.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.70 billion during the quarter, compared to analysts’ expectations of $111.31 billion. The company’s revenue for the quarter was down .4% on a year-over-year basis. During the same period in the previous year, the business posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 20.62 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were given a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date was Monday, September 14th.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.